• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $USER

    UserTesting Inc.

    Subscribe to $USER
    $USER
    Computer Software: Prepackaged Software
    Technology

    UserTesting, Inc. engages in the operation of a software-as-a-service (SaaS) platform that enables organizations to know experiences of people as they engage with products, designs, apps, processes, concepts, or brands in the United States, the United Kingdom, and internationally. Its platform captures customer perspectives from targeted audiences who share their thoughts for digital, real-world, or omnichannel experiences. The company sells through a direct selling motion with field sales representatives; and inside sales organization that sells to mid-market, and small and medium-sized business customers. It serves customers in B2B and B2C technology, health and fitness, retail and apparel, travel and hospitality, financial services, automotive and transportation, food and beverage, consumer products, and other industries. The company was incorporated in 2007 and is based in San Francisco, California.

    IPO Year: 2021

    Exchange: NYSE

    Website: usertesting.com

    Recent Analyst Ratings for UserTesting Inc.

    DatePrice TargetRatingAnalyst
    12/13/2022$7.50Overweight → Neutral
    Piper Sandler
    12/13/2022Strong Buy → Mkt Perform
    Raymond James
    10/19/2022$8.50 → $4.50Overweight → Equal-Weight
    Morgan Stanley
    6/17/2022$14.00 → $12.00Outperform
    Oppenheimer
    12/13/2021$10.00Buy
    Loop Capital
    12/13/2021$15.00Outperform
    Robert W. Baird
    12/13/2021Outperform
    William Blair
    12/13/2021$15.00Buy
    Truist Securities
    12/13/2021$14.00Overweight
    JP Morgan
    12/13/2021$15.00Outperform
    Baird
    See more ratings